Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.92 |
| ▸ | POLB | P06746 | 1/20 | 0.92 |
| ▸ | APEX1 | P27695 | 1/20 | 0.92 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.92 |
| ▸ | RARB | P10826 | 5/20 | 0.66 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10428461 | 0.96 | HTT (1.00) | HTTPOLBAPEX1TDP1RARB | |
| SCHEMBL8678901 | 0.96 | HTT (1.00) | HTTPOLBAPEX1TDP1RARB | |
| SCHEMBL9952684 | 0.96 | HTT (1.00) | HTTPOLBAPEX1TDP1RARB | |
| SCHEMBL10428187 | 0.96 | HTT (1.00) | HTTPOLBAPEX1TDP1RARB | |
| SCHEMBL1309117 | 0.96 | HTT (1.00) | HTTPOLBAPEX1TDP1RARB | |
| SCHEMBL8682933 | 0.96 | HTT (1.00) | HTTPOLBAPEX1TDP1RARB | |
| SCHEMBL8962574 | 0.96 | HTT (1.00) | HTTPOLBAPEX1TDP1RARB | |
| Biphenyl SCHEMBL1493814 | 0.95 | HTT (0.87) | HTTPOLBAPEX1TDP1RARB | |
| SCHEMBL11467186 | 0.94 | HTT (0.97) | HTTPOLBAPEX1TDP1RARB | |
| Hydrochloric Acid SCHEMBL6450158 | 0.94 | HTT (0.97) | HTTPOLBAPEX1TDP1RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916853-B | Polymer, and photo-alignment film and retardation film using the same | 大阪有机化学工业株式会社 | 2024-07-09 | — | — | CN | disclosed |
| WO-2023171757-A1 | POLYMER COMPOSITION, SINGLE LAYER PHASE DIFFERENCE MATERIAL, AND LIQUID CRYSTAL ALIGNMENT AGENT | 日産化学株式会社 | 2023-09-14 | — | — | WO | disclosed |
| WO-2023171760-A1 | PHASE DIFFERENCE FILM COMPOSITION AND SINGLE-LAYER PHASE DIFFERENCE MATERIAL | 日産化学株式会社 | 2023-09-14 | — | — | WO | disclosed |
| WO-2023095925-A1 | POLYMER COMPOSITION AND SINGLE-LAYER RETARDATION MATERIAL | 日産化学株式会社 | 2023-06-01 | — | — | WO | disclosed |
| CN-115916853-A | Novel polymer, and photo-alignment film and retardation film using same | 大阪有机化学工业株式会社 | 2023-04-04 | — | — | CN | disclosed |
| WO-2017170681-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学工業株式会社 | 2017-10-05 | — | — | WO | disclosed |
| US-20120298932-A1 | METAL COMPLEX, COMPOSITION COMPRISING SAME AND LIGHT-EMITTING ELEMENT USING SAME | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2012-11-29 | — | — | US | disclosed |
| EP-2460788-A1 | METAL COMPLEX, COMPOSITION COMPRISING SAME AND LIGHT-EMITTING ELEMENT USING SAME | Sumitomo Chemical Company, Limited (JP) | 2012-06-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120298932-A1 | METAL COMPLEX, COMPOSITION COMPRISING SAME AND LIGHT-EMITTING ELEMENT USING SAME | C1S, AP3M1, AP1M1 | HTT 3049/4885POLB 3800/4885APEX1 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.